MacroNewLimit Raises $435M for Human Trials of Age-Reprogramming DrugNewLimit, the longevity biotech company co-founded by Coinbase CEO Brian Armstrong, raised $435 million in Series C fund...Jun 3, 2026, 09:02 AMNewLimitBrian Armstrong
